Butyrylcholinesterase and disease progression in mild cognitive impairment and early AD

被引：0
|
作者：
Feldman, Howard [1 ]
机构：
[1] Univ British Columbia Hosp, Vancouver, BC, Canada
来源：
NEUROBIOLOGY OF AGING | 2008年 / 29卷
关键词：
Alzheimer disease; mild cognitive impairment; rivastigmine; BuChE genotype; butyrylcholinesterase;
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
17
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [1] Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease
    Gabriel, Antonio Jose
    Almeida, Maria Rosario
    Ribeiro, Maria Helena
    Carneiro, Diogo
    Valerio, Daniela
    Pinheiro, Ana Cristina
    Pascoal, Rui
    Santana, Isabel
    Baldeiras, Ines
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2018, 61 (03) : 1097 - 1105
  • [2] Rates of progression in mild cognitive impairment and early Alzheimer's disease
    Storandt, M
    Grant, EA
    Miller, JP
    Morris, JC
    [J]. NEUROLOGY, 2002, 59 (07) : 1034 - 1041
  • [3] Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment
    Ferris, Steven
    Nordberg, Agneta
    Soininen, Hilkka
    Darreh-Shori, Taher
    Lane, Roger
    [J]. PHARMACOGENETICS AND GENOMICS, 2009, 19 (08): : 635 - 646
  • [4] Progression of mild cognitive impairment to dementia due to AD in clinical settings
    Tifratene, Karim
    Robert, Philippe
    Metelkina, Asya
    Pradier, Christian
    Dartigues, Jean Francois
    [J]. NEUROLOGY, 2015, 85 (04) : 331 - 338
  • [5] Hippocampus and entorhinal cortex in mild cognitive impairment and early AD
    Pennanen, C
    Kivipelto, M
    Tuomainen, S
    Hartikainen, P
    Hänninen, T
    Laakso, MP
    Hallikainen, M
    Vanhanen, M
    Nissinen, A
    Helkala, EL
    Vainio, P
    Vanninen, R
    Partanen, K
    Soininen, H
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 (03) : 303 - 310
  • [6] Quantitative electroencephalography (qEEG) as a prognostic marker of progression in mild cognitive impairment (MCI) and mild Alzheimer's disease (AD)
    Nielsen, M. Schjonning
    Simonsen, A. Hviid
    Hasselbalch, S. G.
    Hogh, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 603 - 603
  • [7] Butyrylcholinesterase: Impact on symptoms and progression of cognitive impairment in dementia
    Ballard, C
    Perry, E
    Lehmann, D
    Wesnes, K
    Holmes, C
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S1 - S1
  • [8] MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment
    Whitwell, J. L.
    Shiung, M. M.
    Przybelski, S. A.
    Weigand, S. D.
    Knopman, D. S.
    Boeve, B. F.
    Petersen, R. C.
    Jack, C. R., Jr.
    [J]. NEUROLOGY, 2008, 70 (07) : 512 - 520
  • [9] Factors associated with progression to probable AD in patients with mild cognitive impairment.
    Rippeth, J
    Lucas, JA
    Ivnik, RJ
    Smith, GE
    Petersen, RC
    Graff-Radford, NR
    [J]. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 1999, 14 (01) : 63 - 63
  • [10] Predictors of progression from mild cognitive impairment to Alzheimer disease
    Rozzini, Luca
    Chilovi, Barbara Vicini
    Trabucchi, Marco
    Padovani, Alessandro
    [J]. NEUROLOGY, 2008, 70 (09) : 735 - 735
12345